Papoutsanis - Public Comps and Valuation Multiples

Papoutsanis Overview

About Papoutsanis

Papoutsanis SA manufactures food, personal care and household cleaning products. The company's products include soap items, cosmetic, shower caps and sewing kits, vanity sets, paper cases, dental kits, shaving set among others.

Founded

1960

HQ

Employees

n/a

Website

papoutsanis.gr

Sectors

Home Care

Financials

LTM Revenue $89.6M

LTM EBITDA $13.3M

EV

$117M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Papoutsanis Financials

As of September 2025, Papoutsanis reported last 12-month revenue of $89.6M and EBITDA of $13.3M.

In the same period, Papoutsanis achieved $7.0M in LTM net income.

See Papoutsanis valuation multiples based on analyst estimates

Papoutsanis P&L

In the most recent fiscal year, Papoutsanis reported revenue of $76.6M and EBITDA of $11.6M.

Papoutsanis expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Papoutsanis valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$89.6M	XXX	$76.6M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$28.6M	XXX	XXX	XXX
Gross Margin	n/a	XXX	37%	XXX	XXX	XXX
EBITDA	$13.3M	XXX	$11.6M	XXX	XXX	XXX
EBITDA Margin	15%	XXX	15%	XXX	XXX	XXX
EBIT	$10.2M	XXX	$24.1M	XXX	XXX	XXX
EBIT Margin	11%	XXX	31%	XXX	XXX	XXX
Net Profit	$7.0M	XXX	$6.1M	XXX	XXX	XXX
Net Margin	8%	XXX	8%	XXX	XXX	XXX
Net Debt	XXX	XXX	$24.8M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Papoutsanis including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $89.6M. EBITDA for the last twelve months was $13.3M. In the most recent fiscal year, Papoutsanis achieved $76.6M in revenue and $11.6M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$89.6M	Analyst estimates available to subscribers	$76.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$28.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	37.3% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$13.3M	Analyst estimates available to subscribers	$11.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	14.8% EBITDA margin	Analyst estimates available to subscribers	15.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$10.2M	Analyst estimates available to subscribers	$24.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	11.4% EBIT margin	Analyst estimates available to subscribers	31.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$7.0M	Analyst estimates available to subscribers	$6.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	7.9% net profit margin	Analyst estimates available to subscribers	8.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$24.8M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Papoutsanis

This financial data table provides comprehensive performance metrics for Papoutsanis, a company based in Greece. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Papoutsanis generated $89.6M in revenue over the last twelve months.
The company achieved $13.3M in EBITDA over the last twelve months.
Net income over the last twelve months reached $7.0M.

Fiscal Year Performance

In the most recent fiscal year, Papoutsanis reported $76.6M in total revenue.
Fiscal year EBITDA was $11.6M.
The company maintained a gross profit margin of 37.3% in the most recent fiscal year.
EBITDA margin for the fiscal year was 15.2%.
Net profit margin reached 8.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Papoutsanis. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Papoutsanis Stock Performance

Papoutsanis has current market cap of EUR 80.3M (or $92.8M), and EV of EUR 101M (or $117M).

Market Cap Evolution

Papoutsanis Stock Data

As of October 13, 2025, Papoutsanis's stock price is EUR 3 (or $3).

See Papoutsanis trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$117M	$92.8M	XXX	XXX	XXX	XXX	$0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Papoutsanis Valuation Multiples

Papoutsanis's trades at 1.5x EV/Revenue multiple, and 10.0x EV/EBITDA.

See valuation multiples for Papoutsanis and 15K+ public comps

Papoutsanis Financial Valuation Multiples

As of October 13, 2025, Papoutsanis has market cap of $92.8M and EV of $117M.

Equity research analysts estimate Papoutsanis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Papoutsanis has a P/E ratio of 13.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$92.8M	XXX	$92.8M	XXX	XXX	XXX
EV (current)	$117M	XXX	$117M	XXX	XXX	XXX
EV/Revenue	1.3x	XXX	1.5x	XXX	XXX	XXX
EV/EBITDA	8.8x	XXX	10.0x	XXX	XXX	XXX
EV/EBIT	11.4x	XXX	4.8x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	13.2x	XXX	15.2x	XXX	XXX	XXX
EV/FCF	76.9x	XXX	-59.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Papoutsanis Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Papoutsanis Margins & Growth Rates

Papoutsanis's last 12 month revenue growth is 12%

Papoutsanis's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Papoutsanis's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Papoutsanis's rule of X is 46% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Papoutsanis and other 15K+ public comps

Papoutsanis Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	12%	XXX	16%	XXX	XXX	XXX
EBITDA Margin	15%	XXX	15%	XXX	XXX	XXX
EBITDA Growth	14%	XXX	16%	XXX	XXX	XXX
Rule of 40	26%	XXX	28%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	46%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	6%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial